Literature DB >> 16328598

Differences in genomic instability between intestinal- and diffuse-type gastric cancer.

Matti Vauhkonen1, Hanna Vauhkonen, Antti Sajantila, Pentti Sipponen.   

Abstract

BACKGROUND: Microsatellite instability (MSI) and loss of heterozygosity (LOH) are lesions in the genome found with different frequencies in gastric carcinomas (GCAs). Despite a great body of studies, no systematic approach to the detailed classification of MSI and LOH in the two major types of GCA has been published.
METHODS: Thirty-seven advanced GCAs, 25 intestinal-type (IGCAs) and 12 diffuse-type (DGCAs), were assayed with 15 autosomal tetranucleotide markers on 14 chromosomal arms. The observed frequencies and types of microsatellite alterations allowed stratification into subgroups, i.e., high- and low-grade MSI (MSI-H, MSI-L) or microsatellite-stable (MSS), and high- or low-grade, or non-detectable LOH (LOH-H, LOH-L, LOH-N).
RESULTS: Collectively, the markers detected MSI-H tumors with sensitivity equal to that of BAT-26 (a single marker highly specific for MSI-H). Likewise, the markers detected LOH at chromosomal arms 5q, 18q, and 21q with a sensitivity equal to markers used previously. Seven (19%) MSI-H and six (16%) LOH-H tumors were found, with a significant association (P = 0.027) with IGCA: 92% of MSI-H and LOH-H occurred in IGCA patients only. Conversely, in DGCA, a significantly higher prevalence of a stable (LOH-N/MSS) phenotype was found as compared with IGCA (75.1% vs 28.0%; P = 0.035). The MSI-L phenotype was found in 57.9% of non-MSI-H IGCA tumors and was associated significantly (P = 0.015) with LOH-H.
CONCLUSION: A clear difference in genomic instability between IGCA and DGCA was found. In IGCA, the MSI and LOH pathways were more commonly involved, whereas in DGCA, a stable phenotype was predominant. As a novel finding, MSI-L as a true phenomenon and its association with LOH was observed in IGCA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16328598     DOI: 10.1007/s10120-005-0346-3

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  41 in total

1.  Targets of gene amplification and overexpression at 17q in gastric cancer.

Authors:  Asta Varis; Maija Wolf; Outi Monni; Marja-Leena Vakkari; Arto Kokkola; Chris Moskaluk; Henry Frierson; Steven M Powell; Sakari Knuutila; Anne Kallioniemi; Wa'el El-Rifai
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

2.  Microsatellite instability in intestinal- and diffuse-type gastric carcinoma.

Authors:  G Buonsanti; D Calistri; L Padovan; O Luinetti; R Fiocca; E Solcia; G N Ranzani
Journal:  J Pathol       Date:  1997-06       Impact factor: 7.996

3.  Target gene mutation profile differs between gastrointestinal and endometrial tumors with mismatch repair deficiency.

Authors:  Alex Duval; Maryline Reperant; Aurore Compoint; Raquel Seruca; Guglielmina N Ranzani; Barry Iacopetta; Richard Hamelin
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

4.  Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.

Authors:  M Toyota; N Ahuja; H Suzuki; F Itoh; M Ohe-Toyota; K Imai; S B Baylin; J P Issa
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

5.  Cellular and molecular pathology of gastric carcinoma and precursor lesions: A critical review.

Authors:  Si-Chun Ming
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

6.  BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines.

Authors:  J M Hoang; P H Cottu; B Thuille; R J Salmon; G Thomas; R Hamelin
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

7.  MSI-low, a real phenomenon which varies in frequency among cancer types.

Authors:  Sarah E R Halford; Elinor J Sawyer; Maryou B Lambros; Patricia Gorman; Nicola D Macdonald; Ian C Talbot; William D Foulkes; Cheryl E Gillett; Diana M Barnes; Lars A Akslen; Kwok Lee; Ian J Jacobs; Andrew M Hanby; Trivadi S Ganesan; Helga B Salvesen; Walter F Bodmer; Ian P M Tomlinson; Rebecca R Roylance
Journal:  J Pathol       Date:  2003-11       Impact factor: 7.996

8.  Abnormalities affecting the APC and MCC tumour suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer.

Authors:  A B McKie; M I Filipe; N R Lemoine
Journal:  Int J Cancer       Date:  1993-10-21       Impact factor: 7.396

Review 9.  Genetic pathways of two types of gastric cancer.

Authors:  Eiichi Tahara
Journal:  IARC Sci Publ       Date:  2004

Review 10.  The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFbeta RII, IGFII R, and BAX genes.

Authors:  C Oliveira; R Seruca; M Seixas; M Sobrinho-Simões
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

View more
  16 in total

1.  Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery.

Authors:  Wen-Liang Fang; Shih-Ching Chang; Yuan-Tzu Lan; Kuo-Hung Huang; Jen-Hao Chen; Su-Shun Lo; Mao-Chih Hsieh; Anna Fen-Yau Li; Chew-Wun Wu; Shih-Hwa Chiou
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

2.  Tumoural specimens for forensic purposes: comparison of genetic alterations in frozen and formalin-fixed paraffin-embedded tissues.

Authors:  Viviana Ananian; Pamela Tozzo; Elena Ponzano; Donato Nitti; Daniele Rodriguez; Luciana Caenazzo
Journal:  Int J Legal Med       Date:  2010-04-06       Impact factor: 2.686

3.  Genetic differences stratified by PCR-based microsatellite analysis in gastric intramucosal neoplasia.

Authors:  Tamotsu Sugai; Ryo Sugimoto; Wataru Habano; Masaki Endoh; Makoto Eizuka; Koudai Tsuchida; Eiichiro Yamamoto; Keisuke Kawasaki; Syunichi Yanai; Takayuki Matsumoto; Hiromu Suzuki
Journal:  Gastric Cancer       Date:  2016-05-28       Impact factor: 7.370

4.  Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.

Authors:  A Gylling; W M Abdel-Rahman; M Juhola; K Nuorva; E Hautala; H J Järvinen; J-P Mecklin; M Aarnio; P Peltomäki
Journal:  Gut       Date:  2007-01-31       Impact factor: 23.059

5.  Epistatic SNP interaction of ERCC6 with ERCC8 and their joint protein expression contribute to gastric cancer/atrophic gastritis risk.

Authors:  Jing-Jing Jing; You-Zhu Lu; Li-Ping Sun; Jing-Wei Liu; Yue-Hua Gong; Qian Xu; Nan-Nan Dong; Yuan Yuan
Journal:  Oncotarget       Date:  2017-06-27

6.  Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.

Authors:  Adriana Camargo Ferrasi; Nídia Alice Pinheiro; Silvia Helena Barem Rabenhorst; Otávia Luisa Caballero; Maria Aparecida Marchesan Rodrigues; Fabrício de Carvalho; Celso Vieira de Souza Leite; Marcia Valéria Pitombeira Ferreira; Marcos Aurélio Pessoa Barros; Maria Inês Moura Campos Pardini
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

7.  The gene-reduction effect of chromosomal losses detected in gastric cancers.

Authors:  Seung-Jin Hong; Eun-Jung Jeon; Jung-Hwan Oh; Eun-Joo Seo; Sang-Wook Choi; Mun-Gan Rhyu
Journal:  BMC Gastroenterol       Date:  2010-11-20       Impact factor: 3.067

8.  Hec1/Ndc80 is overexpressed in human gastric cancer and regulates cell growth.

Authors:  Ying Qu; Jianfang Li; Qu Cai; Bingya Liu
Journal:  J Gastroenterol       Date:  2013-04-17       Impact factor: 7.527

9.  High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability.

Authors:  Karol Polom; Daniele Marrelli; Valeria Pascale; Giandomenico Roviello; Costantino Voglino; Henry Rho; Carla Vindigni; Mario Marini; Raffaele Macchiarelli; Franco Roviello
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-20       Impact factor: 4.553

10.  Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer.

Authors:  Wei-Qing Xu; Ling-Jun Song; Qiang Liu; Lei Zhao; Lin Zheng; Zhao-Wen Yan; Guo-Hui Fu
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-28       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.